Valuation Bausch Health Companies Inc. Toronto S.E.

Equities

Market Closed - Toronto S.E. Other stock markets 16:00:00 2026-01-21 EST			5-day change	1st Jan Change
9.210 ^CAD	-1.81%		-11.01%	-3.36%

01-14	Bausch Health Companies Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 03:45 PM
01-13	Bausch Health Brief: Co Provides Filing Ahead of Participating in 44th Annual J.P. Morgan Healthcare Conference on Jan. 14, 2026	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	7,385	9,921	2,273	2,929	2,964	2,516	2,516	-
Change	-	34.34%	-77.09%	28.88%	1.22%	-15.14%	0%	-
Enterprise Value (EV)	29,494	30,456	2,273	2,929	2,964	2,516	2,516	2,516
Change	-	3.26%	-92.54%	28.88%	1.22%	-15.14%	0%	0%
P/E ratio	-13.2x	-10.5x	-10.1x	-4.95x	-62x	5.55x	4.72x	5.39x
PBR	13.8x	-	-	-	-	-	-	-
PEG	-	-0.2x	0.1x	-0x	0.7x	-0x	0.3x	-0.4x
Capitalization / Revenue	0.92x	1.18x	0.28x	0.33x	0.31x	0.25x	0.24x	0.24x
EV / Revenue	0x	0x	0x	0x	0x	0.25x	0.24x	0.24x
EV / EBITDA	0x	0x	0x	0x	0x	0.71x	0.67x	0.7x
EV / EBIT	0x	0x	0x	0x	0x	0.77x	0.74x	0.77x
EV / FCF	0x	0x	-0x	0x	0x	2.48x	1.09x	0.84x
FCF Yield	11%	11.7%	-41.6%	27.9%	42.5%	40.4%	91.7%	120%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.58	-2.64	-0.62	-1.62	-0.13	1.223	1.44	1.26
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	8,027	8,434	8,124	8,757	9,625	10,178	10,521	10,590
EBITDA ¹	3,294	3,472	3,022	3,014	3,307	3,568	3,738	3,587
EBIT ¹	2,959	2,951	2,775	2,808	3,049	3,277	3,419	3,286
Net income ¹	-560	-948	-225	-592	-46	458	541	474
Net Debt	22,109	20,535	-	-	-	-	-	-
Reference price ²	20.800	27.610	6.280	8.020	8.060	6.790	6.790	6.790
Nbr of stocks (in thousands)	355,053	359,331	361,868	365,195	367,803	370,517	370,517	-
Announcement Date	2/24/21	2/23/22	2/23/23	2/22/24	2/19/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	45.4x	15.04x	33.53x	0.57%	932B
JOHNSON & JOHNSON	21.3x	5.88x	16.33x	2.37%	526B
ABBVIE INC.	60.77x	7.13x	17.1x	3.06%	378B
ROCHE HOLDING AG	20.32x	5.04x	12.55x	2.86%	374B
ASTRAZENECA PLC	27.91x	5.2x	15.4x	1.78%	282B
NOVARTIS AG	20.21x	5.37x	12.59x	2.83%	278B
NOVO NORDISK A/S	16.86x	5.96x	12.33x	2.99%	272B
MERCK & CO., INC.	14.02x	4.6x	9.89x	2.95%	272B
AMGEN INC.	25.87x	6.13x	10.5x	2.89%	178B
Average	28.07x	6.71x	15.58x	2.48%	387.98B
Weighted average by Cap.	31.67x	8.20x	19.12x	2.12%